Home » Topics » Regulatory

Regulatory
RSS

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Cypress Bioscience files PMA for Prosorba Column

July 28, 1998

FDA approves new dosing regimen for SB's amoxicillin

July 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...